Saturday, 31 October 2026European Markets

CATANA GROUP And TRIGANO Have A High Dividend Yield And Return On Equity In The Recreational Vehicles Industry.

Loading stream...

(vianews) - catana group (catg.pa) is among this list of stock assets with the highest dividend rate and return on equity on the recreational vehicles industry.

financial asset price forward dividend yield return on equity
catana group (catg.pa) €4.70 2.69% 28.04%
trigano (tri.pa) €163.00 2.52% 22.93%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. catana group (catg.pa)

2.69% forward dividend yield and 28.04% return on equity

sa catana group manufactures and catamarans and related services in france and internationally. the company markets its products under the catana, bali, and port pin roland brand names. sa catana group was incorporated in 1993 and is headquartered in canet-en-roussillon, france.

earnings per share

as for profitability, catana group has a trailing twelve months eps of €0.63.

pe ratio

catana group has a trailing twelve months price to earnings ratio of 7.46. meaning, the purchaser of the share is investing €7.46 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.04%.

volatility

catana group's last week, last month's, and last quarter's current intraday variation average was a negative 6.07%, a negative 1.10%, and a positive 1.93%.

catana group's highest amplitude of average volatility was 6.07% (last week), 2.22% (last month), and 1.93% (last quarter).

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, catana group's stock is considered to be overbought (>=80).

volume

today's last reported volume for catana group is 31005 which is 51.77% below its average volume of 64291.

yearly top and bottom value

catana group's stock is valued at €4.70 at 22:40 est, way below its 52-week high of €7.55 and above its 52-week low of €4.44.

more news about catana group.

2. trigano (tri.pa)

2.52% forward dividend yield and 22.93% return on equity

trigano s.a., together with its subsidiaries, designs, manufactures, markets, and sells leisure vehicles for individuals and professionals in europe. it offers camping cars, caravans, motorhomes, trailers, and outdoor habitats. the company also provides mobiles homes, spare parts, and accessories, as well as leisure financing services. it offers its products through dealer networks and distributors, as well as through its online sales site, triganostore.com. trigano s.a. was founded in 1935 and is based in paris, france.

earnings per share

as for profitability, trigano has a trailing twelve months eps of €15.95.

pe ratio

trigano has a trailing twelve months price to earnings ratio of 10.22. meaning, the purchaser of the share is investing €10.22 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.93%.

volume

today's last reported volume for trigano is 123943 which is 616.76% above its average volume of 17292.

dividend yield

according to morningstar, inc., the next dividend payment is on may 22, 2024, the estimated forward annual dividend rate is 3.5 and the estimated forward annual dividend yield is 2.52%.

sales growth

trigano's sales growth for the current quarter is 27.5%.

more news about trigano.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com